Why the study?
Is a stepwise multimarker risk stratification strategy cost-effective for predicting cardiac mortality in survivors of acute myocardial infarction?
Is a stepwise multimarker risk stratification strategy cost-effective for predicting cardiac mortality in survivors of acute myocardial infarction?
A stepwise risk stratification strategy using Holter monitoring followed by other non-invasive tests is a cost-effective approach for identifying post-MI patients at high risk of cardiac death.
No takes yet. Share an insight, caveat, or question.
Stepwise testing may lower costs in post-MI survivors; hypothesis-generating and requires randomized trials before practice change.
Oliveira et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: